Nevertheless, HER2 status interpretation, and subsequently, an accurate classification of BC patients, can be affected by several factors, with HER2 heterogeneity being the most important one, as documented elsewhere for other neoplasms [33,41,42]. This evidence concerns the gene ERBB2 and neoplasm.